Today in Brussels, Belgium, the EU-Central Asia Drug Dialogue has began under the chairmanship of the Czech Republic. The purpose of this Dialogue was to strengthen international cooperation, exchange views and support the proper development of drug policy.
CADAP Programme supported the participation in the Dialogue of delegations from 4 Central Asian countries (Kazakhstan, Kyrgyzstan, Turkmenistan, Uzbekistan) among the representatives of relevant state institutions, whose activities include countering drug smuggling and developing state policy in the field of drugs – Ministries of Interior, General Prosecutors’ Offices. The delegates presented reports on the situation in the countries of Central Asia.
EU side was represented by EU Member States and representatives of the EU institutions and agencies such as the European Commission, the European Monitoring Centre of Drugs and Addictions, EUROPOL, the European External Action Service and General Secretariat of the Council of Europe. Particularly, the European Commission presented the EU Drugs Strategy 2021-2025 and its Action Plan 2021-2025 and EU agencies shared the information on recent development in the EU.
Expert dialogues on drugs are the fundamental part of the EU Drugs Strategy 2021-2025 that strongly supports information sharing on the strategies, aims and relevant initiatives through the dialogues on drugs with international partners, both at regional and bilateral level. Dialogues are typically based on multilateral partnership and cooperation with representatives of various regions or EU long-term partners. The goal is to address the experts from the countries outside of the EU and exchange views concerning the drug situation, both at regional and international level.